FDA wants more proof COVID-19 plasma therapy works By Nicoletta Lanese The agency is waiting on more data from "gold standard" clinical trials.
What if a powerful hurricane hits during the pandemic? Here's how to prevent a double disaster. By Nicoletta Lanese A new model hints that sending evacuees to counties with low COVID-19 spread may help minimize cases.
California reports first human plague case in 5 years By Rachael Rettner "Human cases of plague are extremely rare but can be very serious," officials said.
FDA approves new saliva test for COVID-19 that's simple, cheap and available now By Rachael Rettner The test doesn't require any proprietary equipment or technology, meaning designated laboratories could follow a specific protocol to conduct their own tests.
Novavax COVID-19 vaccine enters second round of human trials By Nicoletta Lanese The trial will include 2,665 healthy adults and 240 medically stable adults with HIV.
Depression and anxiety are skyrocketing in young adults amid pandemic By Rachael Rettner The new findings "highlight the broad impact of the pandemic and the need to prevent and treat these conditions," the authors wrote.
Live Science podcast 'Life's Little Mysteries' special report: Coronavirus (Aug. 13) By Live Science Staff In this special episode of Life's Little Mysteries, we'll give you the latest news and answer frequently asked questions about the new coronavirus and COVID-19.
Should you ditch your gaiter as a face mask? Not so fast, scientists say. By Yasemin Saplakoglu Some masks are more protective than others. But a new study didn't show which ones work best.
That COVID-19 vaccine Russia approved? It's only cleared for use in a small group of people. By Nicoletta Lanese The vaccine cannot be fully approved until 2021, according to its registration certificate.
Don't wear masks with valves, CDC says By Rachael Rettner Masks with these one-way valves expel respiratory droplets from the wearer into the air.
Vaping linked with much higher risk of getting COVID-19 By Rachael Rettner The study involved more than 4,300 U.S. teens and young adults.
Could cat drugs treat humans with COVID-19? By Nicoletta Lanese Two experimental drugs for feline coronavirus could show promise against COVID-19.
Russia approves 'Sputnik V' COVID-19 vaccine with little human testing By Nicoletta Lanese Only late-stage human trials can show that a vaccine is both safe and effective.
COVID-19 has fueled more than 2,000 rumors and conspiracy theories By Rachael Rettner Along with the COVID-19 pandemic, the world has faced an "infodemic" of misinformation.
New Zealand reports first local COVID-19 transmission in 102 days By Rachael Rettner The country will reinstate temporary COVID-19 restrictions.
What is brain death? New guidelines offer answers. By Stephanie Pappas Different states and different countries have never fully agreed on the procedure for determining brain death.
New Zealand goes 100 days with no COVID-19 transmission By Jeanna Bryner New Zealand, a country of about 4.8 million, has now gone 100 days without a single locally transmitted case of COVID-19.
Decoys could trick COVID-19, keep humans safe from infection By Nicoletta Lanese A "decoy receptor" could potentially be used as a treatment or prophylactic.
Why do we develop lifelong immunity to some diseases, but not others? By Isobel Whitcomb Why do some diseases infect us again and again?
Could COVID-19 increase the risk of memory loss? By Natalie C. Tronson Will there be a COVID-19-related wave of memory deficits, cognitive decline and dementia cases in the future?
